# OppFi Inc.: financial statements, quarterly

OPFI · NYSE · CIK 1818502 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/opfi.md) · [Financials](/companies/opfi/financials.md) · [Filings](/companies/opfi/filings.md) · [Insiders](/companies/opfi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/opfi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [75.7](/filings/0001818502-24-000019.md) | [65.8 d](/filings/0001818502-26-000019.md) | [63.2](/filings/0001818502-25-000006.md) | [86.3](/filings/0001818502-25-000027.md) | [91.2](/filings/0001818502-25-000057.md) | [80.8 d](/filings/0001818502-26-000019.md) | [90.8](/filings/0001818502-26-000056.md) | [100](/filings/0001818502-26-000075.md) | [105](/filings/0001818502-25-000057.md) | [85.6 d](/filings/0001818502-26-000019.md) | [87.3](/filings/0001818502-26-000056.md) | [86.2](/filings/0001818502-26-000075.md) |
| Operating income | $m | [15.6](/filings/0001818502-24-000019.md) | [8.7 d](/filings/0001818502-26-000019.md) | [5.3](/filings/0001818502-25-000006.md) | [29.5](/filings/0001818502-25-000027.md) | [35.1](/filings/0001818502-25-000057.md) | [24.7 d](/filings/0001818502-26-000019.md) | [42.5](/filings/0001818502-26-000056.md) | [44.8](/filings/0001818502-26-000075.md) | [48.4](/filings/0001818502-25-000057.md) | [30.9 d](/filings/0001818502-26-000019.md) | [35.4](/filings/0001818502-26-000056.md) | [24.4](/filings/0001818502-26-000075.md) |
| Income tax | $m | [0.5](/filings/0001818502-24-000019.md) | [1.0 d](/filings/0001818502-26-000019.md) | [0.4](/filings/0001818502-25-000006.md) | [0.9](/filings/0001818502-25-000027.md) | [2.3](/filings/0001818502-25-000057.md) | [0.6 d](/filings/0001818502-26-000019.md) | [1.7](/filings/0001818502-26-000056.md) | [1.2](/filings/0001818502-26-000075.md) | [5.6](/filings/0001818502-25-000057.md) | [1.4 d](/filings/0001818502-26-000019.md) | [4.0](/filings/0001818502-26-000056.md) | [9.8](/filings/0001818502-26-000075.md) |
| Net income | $m | [2.2](/filings/0001818502-24-000019.md) | [(5.6) d](/filings/0001818502-26-000019.md) | [5.5](/filings/0001818502-25-000006.md) | [3.1](/filings/0001818502-25-000027.md) | [4.3](/filings/0001818502-25-000057.md) | [(5.6) d](/filings/0001818502-26-000019.md) | [(11.4)](/filings/0001818502-26-000056.md) | [(20.8)](/filings/0001818502-26-000075.md) | [41.6](/filings/0001818502-25-000057.md) | [16.8 d](/filings/0001818502-26-000019.md) | [28.4](/filings/0001818502-26-000056.md) | [14.8](/filings/0001818502-26-000075.md) |
| Diluted EPS | $ per share | [0.13](/filings/0001818502-24-000019.md) | not reported | [0.10](/filings/0001818502-25-000006.md) | [0.16](/filings/0001818502-25-000027.md) | [0.21](/filings/0001818502-25-000057.md) | not reported | [(0.48)](/filings/0001818502-26-000056.md) | [(0.78)](/filings/0001818502-26-000075.md) | [0.77](/filings/0001818502-25-000057.md) | not reported | [0.56](/filings/0001818502-26-000056.md) | [0.18](/filings/0001818502-26-000075.md) |
| Basic EPS | $ per share | [0.13](/filings/0001818502-24-000019.md) | not reported | [0.29](/filings/0001818502-25-000006.md) | [0.16](/filings/0001818502-25-000027.md) | [0.21](/filings/0001818502-25-000057.md) | not reported | [(0.48)](/filings/0001818502-26-000056.md) | [(0.78)](/filings/0001818502-26-000075.md) | [1.48](/filings/0001818502-25-000057.md) | not reported | [1.06](/filings/0001818502-26-000056.md) | [0.22](/filings/0001818502-26-000075.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [31.1](/filings/0001818502-23-000016.md) | [31.8](/filings/0001818502-25-000003.md) | [47.2](/filings/0001818502-24-000009.md) | [46.6](/filings/0001818502-24-000015.md) | [44.8](/filings/0001818502-24-000019.md) | [61.3](/filings/0001818502-26-000019.md) | [58.0](/filings/0001818502-25-000006.md) | [45.2](/filings/0001818502-25-000027.md) | [45.5](/filings/0001818502-25-000057.md) | [49.5](/filings/0001818502-26-000075.md) | [63.9](/filings/0001818502-26-000056.md) | [64.3](/filings/0001818502-26-000075.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [601](/filings/0001818502-23-000016.md) | [602](/filings/0001818502-25-000003.md) | [563](/filings/0001818502-24-000009.md) | [573](/filings/0001818502-24-000015.md) | [619](/filings/0001818502-24-000019.md) | [641](/filings/0001818502-26-000019.md) | [640](/filings/0001818502-25-000006.md) | [673](/filings/0001818502-25-000027.md) | [721](/filings/0001818502-25-000057.md) | [754](/filings/0001818502-26-000075.md) | [720](/filings/0001818502-26-000056.md) | [771](/filings/0001818502-26-000075.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [411](/filings/0001818502-23-000016.md) | [408](/filings/0001818502-25-000003.md) | [366](/filings/0001818502-24-000009.md) | [371](/filings/0001818502-24-000015.md) | [399](/filings/0001818502-24-000019.md) | [407](/filings/0001818502-26-000019.md) | [403](/filings/0001818502-25-000006.md) | [456](/filings/0001818502-25-000027.md) | [443](/filings/0001818502-25-000057.md) | [445](/filings/0001818502-26-000075.md) | [377](/filings/0001818502-26-000056.md) | [356](/filings/0001818502-26-000075.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [11.4](/filings/0001818502-23-000016.md) | [10.4](/filings/0001818502-25-000003.md) | [18.2](/filings/0001818502-24-000009.md) | [18.6](/filings/0001818502-24-000015.md) | [34.9](/filings/0001818502-24-000019.md) | [32.8](/filings/0001818502-26-000019.md) | [22.6](/filings/0001818502-25-000006.md) | [13.4](/filings/0001818502-25-000027.md) | [49.4](/filings/0001818502-25-000057.md) | [58.5](/filings/0001818502-26-000075.md) | [75.7](/filings/0001818502-26-000056.md) | [414](/filings/0001818502-26-000075.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [75.0 d](/filings/0001818502-24-000019.md) | [82.6 d](/filings/0001818502-26-000019.md) | [74.4](/filings/0001818502-25-000006.md) | [77.3 d](/filings/0001818502-25-000027.md) | [77.6 d](/filings/0001818502-25-000057.md) | [94.5 d](/filings/0001818502-26-000019.md) | [83.7](/filings/0001818502-26-000056.md) | [95.6 d](/filings/0001818502-26-000075.md) | [105 d](/filings/0001818502-25-000057.md) | [117 d](/filings/0001818502-26-000019.md) | [90.8](/filings/0001818502-26-000056.md) | [92.0 d](/filings/0001818502-26-000075.md) |
| Capital expenditure | $m | [2.3 d](/filings/0001818502-24-000019.md) | [2.1 d](/filings/0001818502-26-000019.md) | [2.1](/filings/0001818502-25-000006.md) | [2.6 d](/filings/0001818502-25-000027.md) | [3.9 d](/filings/0001818502-25-000057.md) | [4.4 d](/filings/0001818502-26-000019.md) | [4.4](/filings/0001818502-26-000056.md) | [4.6 d](/filings/0001818502-26-000075.md) | [5.2 d](/filings/0001818502-25-000057.md) | [4.9 d](/filings/0001818502-26-000019.md) | [5.1](/filings/0001818502-26-000056.md) | [4.6 d](/filings/0001818502-26-000075.md) |
| Dividends paid | $m | [0.0 d](/filings/0001818502-24-000019.md) | [0.0 d](/filings/0001818502-26-000019.md) | not reported | not reported | [0.0 d](/filings/0001818502-25-000057.md) | [0.0 d](/filings/0001818502-26-000019.md) | not reported | not reported | [0.0 d](/filings/0001818502-25-000057.md) | [0.0 d](/filings/0001818502-26-000019.md) | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001818502-24-000019.md) | [0.0 d](/filings/0001818502-26-000019.md) | not reported | not reported | [1.0 d](/filings/0001818502-25-000057.md) | [0.0 d](/filings/0001818502-26-000019.md) | [0.0](/filings/0001818502-26-000056.md) | [0.0 d](/filings/0001818502-26-000075.md) | [7.4 d](/filings/0001818502-25-000057.md) | [8.2 d](/filings/0001818502-26-000019.md) | [9.9](/filings/0001818502-26-000056.md) | [1.2 d](/filings/0001818502-26-000075.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.0](/filings/0001818502-23-000016.md) | [15.2](/filings/0001818502-24-000009.md) | [15.9](/filings/0001818502-24-000015.md) | [17.1](/filings/0001818502-24-000019.md) | [86.2](/filings/0001818502-25-000006.md) | [19.7](/filings/0001818502-25-000027.md) | [20.2](/filings/0001818502-25-000057.md) | [23.7](/filings/0001818502-26-000056.md) | [26.6](/filings/0001818502-26-000075.md) | [88.2](/filings/0001818502-25-000057.md) | [86.2](/filings/0001818502-26-000056.md) | [86.0](/filings/0001818502-26-000075.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 87,306,132 at 2025-08-05, from the cover of the [10-Q filed 2025-08-07](/filings/0001818502-25-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.